27 January 2012 Business
Industry news, February 2012
Generic drugs heavyweight Actavis is selling off a subsidiary based in Foshan, China. The business is being bought by Zhejiang Chiral Medicine Chemicals for an undisclosed sum.
In a company statement, Actavis stressed that the company ‘intends to continue further commercial operations in
12 September 2014 News and Analysis
Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerat...
11 September 2014 News and Analysis
Team behind the bendy e-reader display hope to have a full colour graphene-based smartphone style screen within a year
8 September 2014 Research
Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety